<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Differentiated thyroid cancer":41,
"lenvatinib":29,
"tyrosine kinase inhibitor":20,
"oncology":18,
"papillary microcarcinoma":5,
"risk":6,
"thyroid cancer":295,
"Thyroid neoplasms":72,
"Ultrasonography":62,
"Proteomics":8,
"Thymoma":3,
"Breast neoplasms":11,
"Trastuzumab":3,
"Radioiodine":12,
"SOMATIC MUTATION":3,
"Elastography":14,
"Parathyroid":8,
"Thyroid":156,
"Ultrasound":60,
"breast cancer":77,
"mutation":14,
"next-generation sequencing":6,
"core needle biopsy":8,
"diagnosis":31,
"neoplasm":6,
"pathology":19,
"thyroid nodule":90,
"active surveillance":13,
"surgery":27,
"AKT":7,
"epidemiology":18,
"hypothyroidism":13,
"thyroidectomy":63,
"thyroid/parathyroid":15,
"extrathyroidal extension":11,
"thermal ablation":10,
"Bethesda":5,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":12,
"thyroid gland":21,
"thyroid neoplasm":27,
"lymph node dissection":7,
"lymph nodes":10,
"metastasis":58,
"prognostic factors":3,
"cabozantinib":7,
"Computed tomography":7,
"Papillary thyroid carcinoma":201,
"Radioactive iodine ablation":3,
"Bethesda system":10,
"malignancy":19,
"thyroid nodules":56,
"Chernobyl":5,
"radiation exposure":4,
"thyroid surgery":14,
"Case report":9,
"American Thyroid Association":4,
"Children":8,
"Thyroid carcinoma":71,
"Cancer":77,
"Mitochondria":4,
"Medullary thyroid carcinoma":40,
"Cancer therapy":3,
"Diabetes":7,
"Carcinoma, papillary":7,
"Neoplasm metastasis":10,
"Programmed death-ligand 1":4,
"BRAF mutation":15,
"Adenoma":3,
"chemotherapy":13,
"cisplatin":6,
"calcitonin":18,
"observation":4,
"biomarker":18,
"prognosis":71,
"Central lymph node metastasis":5,
"Multifocality":5,
"fine needle aspiration cytology":10,
"hyperparathyroidism":6,
"parathyroid carcinoma":7,
"Immunohistochemistry":51,
"follicular carcinoma":8,
"papillary carcinoma":23,
"Lung adenocarcinoma":10,
"Molecular":5,
"Papillary":9,
"anaplastic":5,
"staging":4,
"TTF-1":7,
"pediatric thyroid cancer":4,
"Bone metastases":3,
"cytopathology":4,
"recurrence":34,
"carcinoma":24,
"Neck Dissection":14,
"Guideline":4,
"Metastases":7,
"Safety":3,
"Medullary thyroid cancer":17,
"pregnancy":8,
"dabrafenib":6,
"trametinib":6,
"undifferentiated":4,
"hyperthyroidism":17,
"radioiodine therapy":13,
"Invasion":26,
"quality of life":12,
"Follicular variant":5,
"Proliferation":29,
"Pyruvate kinase M2":3,
"Lymph node metastases":9,
"Microcarcinoma":8,
"Survival rate":3,
"cohort study":5,
"NIFTP":21,
"follicular variant of papillary thyroid carcinoma":8,
"anaplastic thyroid carcinoma":22,
"follicular thyroid carcinoma":19,
"molecular pathology":4,
"poorly differentiated thyroid carcinoma":11,
"multiple endocrine neoplasia":6,
"poorly differentiated":3,
"Pheochromocytoma":7,
"BRAFV600E":7,
"NF-κB":5,
"Vemurafenib":3,
"Cancer stem cells":3,
"epigenetics":6,
"prognostic factor":4,
"EMT":8,
"Pyruvate kinase":3,
"ovarian cancer":6,
"head and neck cancer":16,
"radiation therapy":4,
"thyroid function":4,
"anaplastic thyroid cancer":20,
"YAP":3,
"Nivolumab":7,
"FTC":4,
"gene expression":8,
"Chronic lymphocytic thyroiditis":5,
"PTC":11,
"cell proliferation":13,
"long non-coding RNA":7,
"FNA":8,
"Fine needle aspiration":17,
"Follow-up":6,
"Nodule":3,
"Prospective study":3,
"Radiofrequency ablation":8,
"Tumor":4,
"Benign thyroid nodule":4,
"Laser":4,
"Graves’ disease":7,
"apoptosis":27,
"China":3,
"Incidence":30,
"Mortality":15,
"immunology":5,
"Body mass index":5,
"incidental findings":3,
"Squamous cell carcinoma":15,
"Hypertension":4,
"Targeted therapy":11,
"lymph node metastasis":30,
"mutations":4,
"miR-144":3,
"papillary thyroid cancer":79,
"HBME-1":3,
"galectin-3":6,
"thyroid tumors":4,
"tyrosine kinase inhibitors":13,
"Parathyroid adenoma":4,
"Shear wave elastography":8,
"thyroglossal duct cyst":4,
"CD56":5,
"fine-needle aspiration cytology":7,
"immunocytochemistry":3,
"prostate cancer":4,
"RET":10,
"cancer immunotherapy":3,
"lymph node":11,
"Triple-negative breast cancer":6,
"Meta-analysis":39,
"Positron emission tomography":6,
"Systematic review":6,
"Cowden syndrome":3,
"PTEN":4,
"thyroid papillary carcinoma":6,
"Histopathology":5,
"thyroid diseases":3,
"Methylation":4,
"Bcl-2":3,
"Complications":4,
"PKM2":9,
"glycolysis":6,
"mTOR":5,
"total thyroidectomy":11,
"PD-1":6,
"radiotherapy":21,
"Complication":3,
"survival":36,
"Hyperspectral imaging":3,
"head and neck surgery":6,
"immunotherapy":19,
"lymphoma":5,
"paclitaxel":3,
"tumor suppressor":3,
"Metabolomics":3,
"Differential diagnosis":4,
"risk stratification":6,
"BRAF":19,
"squamous":3,
"Hürthle cell":4,
"Metabolism":6,
"Laryngeal cancer":4,
"Distant metastasis":3,
"Risk factor":9,
"Follicular adenoma":8,
"Population-based":5,
"Robotic thyroidectomy":6,
"Transoral thyroidectomy":4,
"Papillary thyroid microcarcinoma":15,
"Variant":3,
"head and neck":13,
"oral cancer":4,
"screening":11,
"RET proto-oncogene":7,
"cell cycle":6,
"hepatocellular carcinoma":16,
"colorectal cancer":5,
"thyroid transcription factor-1":3,
"fine-needle aspiration":33,
"follicular neoplasm":4,
"thyroid cytology":6,
"MEN2":5,
"differentiated thyroid carcinoma":27,
"thyroglobulin":24,
"second primary cancer":3,
"dosimetry":3,
"cytology":27,
"well-differentiated thyroid cancer":3,
"Growth":3,
"lung metastasis":7,
"Endoscopic thyroidectomy":4,
"Non-coding RNA":3,
"thyroid hormones":10,
"triiodothyronine":4,
"Melanoma":6,
"PET/CT":9,
"insulin resistance":4,
"metabolic syndrome":3,
"lncRNAs":4,
"oncogene":8,
"Breast neoplasm":4,
"follow-up studies":3,
"iodine radioisotopes":10,
"ionizing radiation":5,
"review":5,
"dynamic risk stratification":5,
"pediatrics":6,
"treatment outcome":4,
"pediatric":3,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":9,
"risk of malignancy":6,
"Doppler":3,
"Resveratrol":6,
"Surveillance":8,
"Primary hyperparathyroidism":8,
"follicular thyroid cancer":9,
"immune checkpoint inhibitors":5,
"lung cancer":14,
"Metformin":6,
"Synergism":3,
"frozen section":4,
"hypoparathyroidism":3,
"Gastric cancer":13,
"hyperplasia":3,
"Ras":4,
"Outcomes":8,
"Wnt/β-catenin signaling pathway":3,
"multiple endocrine neoplasia type 2":4,
"Machine learning":3,
"Radiomics":4,
"LncRNA":7,
"Tumor staging":3,
"esophageal cancer":3,
"Positron emission tomography computed tomography":3,
"Endoscopy":4,
"autophagy":8,
"Epithelial-mesenchymal transition":5,
"DNA methylation":7,
"Inflammation":4,
"Central lymph node dissection":3,
"SPECT/CT":3,
"microRNA":14,
"papillary thyroid carcinoma (PTC)":10,
"TI-RADS":8,
"CXCR4":3,
"computer-assisted":3,
"pattern recognition":4,
"MRI":3,
"ROS":5,
"Iodine":8,
"Overall survival":15,
"Guidelines":6,
"Well-differentiated thyroid carcinoma":3,
"ACTH = adrenocorticotropic hormone":4,
"GH = growth hormone":3,
"TSH = thyroid-stimulating hormone":4,
"pituitary adenoma":6,
"Medullary":7,
"Radioactive iodine":15,
"Hurthle cell carcinoma":3,
"Age":7,
"Colon cancer":5,
"Autoimmune thyroiditis":4,
"Microwave ablation":4,
"BRAF V600E":8,
"RAS mutations":5,
"Thyroid Imaging Reporting and Data System":4,
"Risk assessment":4,
"Hürthle cell carcinoma":3,
"Central Neck Dissection":3,
"xerostomia":3,
"CT":3,
"PET":3,
"imaging":4,
"incidental":4,
"whole exome sequencing":3,
"molecular diagnostics":3,
"thyroid disease":15,
"artificial intelligence":4,
"Adolescents":3,
"tumorigenesis":4,
"Liquid-based cytology":4,
"molecular testing":7,
"renal cell carcinoma":10,
"Long noncoding RNA":4,
"TIRADS":3,
"Thyroid ultrasound":7,
"angiogenesis":5,
"neoplasms":15,
"Migration":11,
"progression-free survival":3,
"sorafenib":13,
"thyroid tumor":5,
"PD-L1":6,
"SEER":11,
"tumor size":3,
"biomarkers":11,
"miRNA":6,
"Sanger sequencing":3,
"Fine needle aspiration (FNA)":3,
"Extranodal extension":3,
"radiosensitivity":4,
"treatment":9,
"trends":3,
"Iodine-131":4,
"sporadic":3,
"TSH":9,
"Biopsy, fine-needle":5,
"Thyroid cancer, papillary":4,
"Disease-free survival":4,
"molecular biology":3,
"endocrine surgery":4,
"general surgery":3,
"Adenocarcinoma":4,
"Follicular":7,
"Struma ovarii":5,
"p53":3,
"Histology":3,
"TNM staging":6,
"Overdiagnosis":8,
"Radiation":11,
"Larynx":3,
"Occult thyroid carcinoma":3,
"Docetaxel":3,
"endocrine cancer":7,
"drug resistance":3,
"Papillary thyroid cancer (PTC)":3,
"Fatigue":4,
"Levothyroxine":6,
"Pituitary":3,
"X-ray":3,
"18F-FDG PET/CT":3,
"hypoxia":3,
"thyroid lobectomy":6,
"Thyroid metastasis":4,
"progression":6,
"Bethesda classification":3,
"Indeterminate":4,
"glucose metabolism":3,
"Giant cell tumor":3,
"Cohort studies":5,
"MET":3,
"epidermal growth factor receptor":3,
"Hashimoto’s thyroiditis":3,
"refractory":3,
"lung":4,
"indeterminate cytology":6,
"Triple negative breast cancer":3,
"genetics":7,
"molecular diagnosis":3,
"NSCLC":3,
"parathyroid glands":3,
"Liver cancer":4,
"Thyroid hormone":3,
"Tumor microenvironment":4,
"Microwave":3,
"Biopsy, large-core needle":3,
"Nódulo tiroideo":5,
"Thyroxine":5,
"Spindle cell oncocytoma":3,
"Diagnostic":5,
"CK19":3,
"thyroid peroxidase":3,
"Neuroendocrine carcinoma":3,
"proteinuria":4,
"Breast":3,
"thyrotoxicosis":3,
"non-small cell lung cancer":6,
"pancreatic ductal adenocarcinoma":3,
"bioinformatics":3,
"osteosarcoma":3,
"Epithelial mesenchymal transition":3,
"magnetic resonance imaging":7,
"pancreatic cancer":4,
"risk factors":12,
"adrenal insufficiency":3,
"pituitary surgery":4,
"Laryngectomy":3,
"cancer risk":3,
"carcinosarcoma":3,
"Nanoparticles":3,
"multinodular goiter":4,
"nodules":3,
"β-catenin":4,
"Obesity":5,
"Classification":4,
"Estrogen receptor":3,
"Ki-67":4,
"vandetanib":5,
"incidentaloma":5,
"EGFR":4,
"thyroiditis":6,
"TERT promoter mutation":4,
"neoadjuvant chemotherapy":3,
"transoral":5,
"outcome":4,
"robotic surgery":4,
"Afirma":3,
"Contrast-enhanced ultrasound":3,
"Radioresistance":4,
"next generation sequencing":4,
"Fine-needle biopsy":3,
"Otolaryngology":3,
"mass spectrometry":4,
"young adults":3,
"fine-needle aspiration biopsy":6,
"Gene therapy":3,
"Procalcitonin":3,
"Thyroid malignancy":6,
"thyroid stimulating hormone":3,
"Nasopharyngeal carcinoma":5,
"carcinogenesis":3,
"hypercalcemia":3,
"recurrent laryngeal nerve":8,
"prevalence":5,
"Hemithyroidectomy":3,
"Hashimoto thyroiditis":4,
"neuroendocrine tumors":3,
"Ablation techniques":4,
"High-intensity focused ultrasound ablation":3,
"Interventional ultrasonography":3,
"Nodular goitre":3,
"Sarcoma":3,
"esophageal squamous cell carcinoma":5,
"ATC":4,
"Reactive oxygen species":3,
"fine-needle aspiration (FNA)":4,
"Differentially expressed genes":4,
"doxorubicin":5,
"human":3,
"efficacy":3,
"diagnostic accuracy":3,
"TERT":7,
"Hemangioma":3,
"genome-wide association study":3,
"radioiodine treatment":3,
"chemokines":3,
"positron emission tomography/computed tomography":3,
"endocrine":3,
"organ system pathology":3,
"pathology competencies":3,
"clinical features":3,
"biopsy":5,
"SOX2":3,
"STAT3":6,
"pembrolizumab":3,
"Therapy":4,
"Fluorodeoxyglucose":3,
"Thyroid hormone receptor":3,
"Hashimoto's thyroiditis":5,
"CTLA-4":3,
"hypophysitis":5,
"thyroid disorders":5,
"Thyroid-stimulating hormone":4,
"prediction":3,
"radioactive iodine therapy":5,
"Exosomes":3,
"The Cancer Genome Atlas":5,
"Whole-exome sequencing":3,
"health-related quality of life":3,
"lobectomy":6,
"Mouse models":3,
"cyclin D1":3,
"genomics":3,
"transcriptome":3,
"Pituitary neoplasms":3,
"Transcription":3,
"cytotoxicity":3,
"Circular RNA":5,
"completion thyroidectomy":3,
"Scoring system":3,
"Lymphocyte-to-monocyte ratio":3,
"polymorphism":5,
"susceptibility":3,
"HCC":3,
"survival analysis":4,
"clinical trial":3,
"Ectopic thyroid":3,
"neoplasia":3,
"long noncoding RNAs":3,
"lymphatic metastasis":3            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
